Mebutan Dispers

Nabumetone, the active ingredient in Mebutan Dispers, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats rheumatoid arthritis, osteoarthritis and musculoskeletal pain in adults.\n\nGNH India supplies Mebutan Dispers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nabumetone is an NSAID indicated for inflammatory joint disorders and related musculoskeletal pain.\n\nRheumatoid arthritis: reduces joint inflammation and pain, improving mobility.\nOsteoarthritis: alleviates chronic joint pain and enhances functional ability.\nMusculoskeletal pain: provides analgesic and anti‑inflammatory relief for acute or chronic soft‑tissue conditions.

Nabumetone may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Gastrointestinal discomfort or dyspepsia\n- Nausea or vomiting\n- Headache\n- Dizziness\n- Mild skin rash\n- Elevated liver enzymes\n\nSerious or Rare Side Effects:\n- Peptic ulcer disease or gastrointestinal bleeding\n- Hepatotoxicity\n- Acute renal impairment\n- Severe skin reactions such as Stevens‑Johnson syndrome\n- Anaphylaxis\n- Cardiovascular events including myocardial infarction or stroke

When prescribing or using Mebutan Dispers, consider the following precautions.\n\nRenal function assessment: monitor creatinine and clearance in patients with kidney disease.\nHepatic monitoring: check liver enzymes periodically, especially in patients with pre‑existing liver conditions.\nUse lowest effective dose: limit exposure to reduce risk of gastrointestinal and cardiovascular events.\nAvoid in active ulcer disease: contraindicated in patients with current peptic ulcers.\nCaution with anticoagulants: increased bleeding risk when combined with warfarin or similar agents.\nStore at room temperature: keep in the original pack, protect from moisture and light.

Nabumetone can interact with several medicines; awareness helps prevent adverse outcomes.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): heightened bleeding risk.\n- ACE inhibitors or ARBs: may reduce renal function.\n- Lithium: increased lithium serum levels.\n\nModerate Interactions (Monitor Closely):\n- Diuretics: potential for reduced renal perfusion.\n- SSRIs or SNRIs: additive risk of gastrointestinal bleeding.